Pharma Journalist -

AbbVie announced that RINVOQ (upadacitinib) is indicated in the U.S. for the treatment of pediatric patients two years of age and older with active polyarticular juvenile idiopathic…
Read More...

Johnson & Johnson announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking to expand the indication of PREZCOBIX…
Read More...

AstraZeneca announced the successful completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation…
Read More...

Quince Therapeutics, Inc., a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patient’s own biology to deliver rare disease…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application and granted Priority Review to inavolisib, an investigational, oral…
Read More...

Bristol Myers Squibb announced that the European Commission (EC) has approved Opdivo (nivolumab) in combination with cisplatin and gemcitabine for the first-line treatment of adult…
Read More...

Merck, known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, announced that the companies…
Read More...

Merck, a leading science and technology company, has launched its M-Trace Software & Mobile App, a comprehensive data tracking solution to digitize sterility testing. The software…
Read More...

The 4th Next Generation Gene Therapy Vectors Summit is just around the corner! Delivery is cited by many in the gene therapy field as the limiting factor for R&D progress. As such,…
Read More...

HanAll Biopharma Co., Ltd., a global biopharmaceutical company committed to discovering and developing innovative medicines for patients, has signed an exclusive licensing agreement…
Read More...